ArticleTransplantation direct2022

Belatacept Treatment of Recurrent Late-onset T Cell-mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient.

Göran B Klintmalm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.